Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Does Semaglutide Increase Risk for Optic Neuropathy?
TOPLINE: The use of semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), is not associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) in patients with type 2 diabetes, obesity, or both conditions. METHODOLOGY: Researchers conducted…
English